INVESTOR ALERT: Electronic Arts Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Electronic Arts Inc. ("EA" or "the Company") (NASDAQ:EA) for violations of the securities laws. The investigation focuses on whether the Company issued false […]

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Reckitt Benckiser Group plc For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt Benckiser Group plc ("Reckitt" or "the Company") (OTC PINK:RBGLY) for violations of the securities laws. The investigation focuses on whether the Company

INVESTOR ALERT: The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against MGP Ingredients, Inc.

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

SHAREHOLDER ALERT: The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Transocean Ltd.

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Transocean Ltd. ("Transocean" or "the Company") (NYSE:RIG) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

INVESTOR ALERT: XBiotech Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

INVESTOR ALERT: The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Cardlytics, Inc.

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

Polestar Automotive Holding UK PLC Is Being Sued For Securities Fraud And Impacted Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Polestar Automotive Holding UK PLC ("Polestar" or "the Company") (NASDAQ: PSNY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule

SHAREHOLDER ALERT: The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Dave Inc. For Securities Law Violations

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dave Inc. ("Dave" or "the Company") (NASDAQ:DAVE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

INVESTOR ALERT: The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Regeneron Pharmaceuticals, Inc.

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

SHAREHOLDER ALERT: TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of the securities laws. The investigation focuses on whether the Company issued false

Scroll to Top